Business Wire
Monday, November 25, 2013 11:27 AM IST (05:57 AM GMT)
Editors: General: Consumer interest; Business: Business services, Healthcare, biotechnology & pharmaceutical; Healthcare
(BW)(RESEARCHDX)ResearchDx, the Leading Contract Diagnostics Organization, Expands Operations into India

Mumbai, Maharashtra, India, Monday, November 25, 2013 — (Business Wire India) —

ResearchDx, LLC of Irvine, California, USA today announced an expansion of its operations to focus on the important Indian biopharmaceutical and diagnostics markets.

As part of this initiative, ResearchDx will be presenting at the BioPharma India Convention 2013 Meeting in Mumbai, India, held November 25th-26th. “We are proud to be involved as a sponsor of the BioPharma India Convention 2013 meeting. This meeting brings together the key diagnostics and biopharmaceutical companies in the region and is the ideal venue to highlight our services” said Dr. Philip Cotter, Principal and Co-Founder of ResearchDx.

As a Contract Diagnostics Organization, ResearchDx is targeting two major areas for Indian clients. “We can provide a strategic partnership to Indian companies looking to develop companion diagnostics or in vitro diagnostic products for the local, US or European markets. We provide a full range of companion diagnostics and in vitro diagnostics services” said Dr. Mathew Moore, Co-Founder and Principal at ResearchDx.

In addition, ResearchDx provides comprehensive services to assist International Clinical Laboratories obtain US CLIA certification, as well as various additional Clinical Laboratory accreditations such as ISO or College of American Pathologists (CAP). “International CLIA certification, and ISO or CAP accreditation provides our clients with a competitive edge. These licensures have enabled our clients to successfully compete for multi-national based clinical trial studies,” said Dr. Philip Cotter.

ResearchDx is the leading Contract Diagnostics Organization (CDO) for the biopharmaceutical and diagnostic industries. The company provides comprehensive, integrated, flexible services for the in vitro diagnostic development process. From initial assay conceptualization, discovery, optimization and validation in a CAP/CLIA laboratory environment, through a complete set of clinical research services and on to regulatory approval, ResearchDx offers the services and solutions to meet complex diagnostics development needs. ResearchDx’s primary service areas include assay research and development, clinical laboratory services, clinical research, diagnostic manufacturing, and consulting. Additional information is available at

Philip D. Cotter, PhD, FACMG, FFSc(RCPA)
866-225-9195 / 510-332-0477